Drugs / Fibrin Sealant 2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00307515 | Feb → Dec 2006 | — | Ethicon, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibrin Sealant 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307515 ↗ |
| Known as | FS2 | “Fibrin Sealant 2 (FS2)” NCT00307515 ↗ |
| Modality | Protein / enzyme biologic | “Biological Active Component containing Human Fibrinogen 55-85 mg/mL” NCT00307515 ↗ |